Cancer Drug Resistance
Faculty of Health and Medical Sciences, Department of Immunology & Microbiology, University of Copenhagen, Copenhagen, Denmark.
Faculty of Health and Medical Sciences, Department of Immunology & Microbiology, University of Copenhagen, Copenhagen, Denmark.
Topic: The ABC of MDR
Deputy Director for Intramural Research at the National Institutes of Health and Chief of the Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute.
Topic: Development of a Zebrafish model to study the role of ABC transporters at the Blood-Brain Barrier
Senior researcher at the Helmholtz Centre for Environmental Research (UFZ) in Leipzig, Germany.
Topic: Active transport in the context of ADME in the zebrafish embryo
Professor, School of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
Topic: Use of a TR-FRET assay to explore inhibitor and substrate binding in ABCG2
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, Queens, NY, USA.
Topic: A new model for allocrite transport by P-glycoprotein
Associate Investigator, Edison Biotechnology Institute Associate Professor, Microbiology Heritage College of Osteopathic Medicine, Biomedical Sciences, Ohio University. USA.
Topic: Extracellular ATP-induced and ABC transporter-mediated drug resistance in human cancer cells
The Senior Investigator and Program Director, Medical Oncology Fellowship Program, National Cancer Institute, National Institutes of Health in Bethesda.
Topic: Widely deployed genomic analyses lack meaningful information on mechanisms of drug resistance
Professor of Medicine at Columbia University Irving Medical Center
